Evofem Biosciences
EVFM · OTC
$0.0063+$0.00 (+0.00%)TodayMarket closed ·
Prev close $0.0063
EPS: actual vs estimate
Beat the estimate in 4 of the last 8 quarters, by 95.7% on average
Reported EPS
Estimated EPS
| Quarter | Estimate | Reported | Surprise |
|---|---|---|---|
| Q4 FY24 | $0.00 | -$0.03 | +0.0% |
| Q4 FY23 | -$0.6222 | -$0.44 | +29.3% |
| Q3 FY23 | -$0.0612 | $0.10 | +263.4% |
| Q4 FY22 | -$26.77 | -$38.75 | −44.7% |
| Q3 FY22 | -$31.88 | -$5.00 | +84.3% |
| Q2 FY22 | -$124.95 | -$571.25 | −357.2% |
| Q1 FY22 | -$382.50 | -$360.00 | +5.9% |
| Q4 FY21 | -$435.09 | -$618.75 | −42.2% |
Earnings calls
- Special Call - Evofem Biosciences, Inc.
- Special Call - Evofem Biosciences, Inc.
- Special Call - Evofem Biosciences, Inc.
- Special Call - Evofem Biosciences, Inc.
- Virtual Investor Ask the CEO Conference
- Special Call - Evofem Biosciences, Inc.
- EVFM - Earnings call Q2 2022
- EVFM - Earnings call Q1 2022
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.